Developing myocardium is more dependent on glycolysis than adult myocardium, yet the effects of selectively inhibiting glycolysis versus oxidative phosphorylation on embryonic heart function have not been well characterized. Accordingly, we investigated how selective metabolic inhibition affects membrane voltage and intracellular Ca (Ca i) transients in embryonic mouse hearts, including their susceptibility to arrhythmias. A total of 136 isolated embryonic mouse hearts were exposed to either 1) 2-deoxyglucose (2DG; 10 mM) or iodoacetate (IAA; 0.1 mM) with 10 mM pyruvate in place of glucose to selectively inhibit glycolysis or 2) the mitochondrial uncoupler protonophore carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP; 500 nM) with 10 mM glucose present to selectively inhibit oxidative phosphorylation. Using confocal imaging, we found that mitochondrial membrane potential monitored with tetramethylrhodamine methyl ester (200 nM) remained stable with 2DG or IAA but depolarized within 5 min after exposure to FCCP. IAA and FCCP decreased heart rate, inhibited Cai transient amplitude, shortened action potential duration at 80% repolarization (APD80), and prolonged atrioventricular conduction time to similar extents. Although 2DG decreased heart rate and Cai transient amplitude, it did not significantly affect APD80 and AV conduction time. In addition, spontaneous arrhythmias occurred in 77 of 136 embryonic hearts (57%) after exposure to IAA (28/53) or FCCP (49/83). There were no significant differences in the types or incidence of arrhythmias induced by IAA and FCCP. These data support the idea that both glycolysis and oxidative phosphorylation play critical metabolic roles in regulating cardiac function in the embryonic mouse heart. embryonic heart development; calcium transient; arrhythmias THE EMBRYONIC HEART operates and develops normally in a relatively hypoxic microenvironment. During embryogenesis, cardiac mitochondria convert fatty acids to energy at a very low rate compared with adult heart (25, 26) and glycolysis contributes more substantially to overall ATP production (17). This confers a benefit to the developing heart, since glucose requires less O 2 than fatty acids to produce a given amount of ATP. Previous studies have shown that hypoxia causes less severe suppression of mechanical function in neonatal rabbit and canine hearts than in adult hearts from these species (14). It has been proposed, therefore, that embryonic and newborn hearts are better adapted to support mechanical function during hypoxia via enhanced metabolic flux through the glycolytic pathway.
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On the other hand, mitochondria are abundant at early stages in embryonic hearts. The percent volume of mitochondria in rat myocytes was 17% at embryonic day 14 (E14) and increased to 35% at birth (12) . In chicken embryos at Hamburg-Hamilton stages 18 to 29 (equivalent to mouse E11.5 to E14), mitochondrial-to-cell volume averaged 11% (7) . As early as HamburgHamilton stage 12 (approximately equivalent to E10 in the mouse embryo), electron micrographs showed that mitochondria were visible throughout the cytoplasm, although they were not specifically aligned with the myofilaments as in adult myocytes (20) .
In the present study, we investigated the functionality of mitochondria in embryonic mouse heart during early cardiogenesis by comparing the effects of selective inhibition of oxidative phosphorylation versus glycolysis on action potential duration (APD), intracellular Ca (Ca i ) transients, and heart rhythm. Using optical mapping techniques to record mitochondrial membrane potential (⌬⌿ m ), sarcolemmal membrane potential, and Ca i in embryonic mouse hearts, we found that selective inhibition of oxidative phosphorylation or glycolysis has roughly equivalent effects of decreasing heart rate, shortening APD, suppressing the amplitude of Ca i transients, prolonging atrioventricular (AV) conduction time, and causing arrhythmias. These findings support the hypothesis that oxidative phosphorylation and glycolysis are both critically important for embryonic cardiac function.
METHODS
Preparation and solutions. CD-1 mice were time-mated, and the day on which copulation plugs were observed was designated day 0.5 of pregnancy. On the desired gestational day, pregnant female mice were first sedated by inhalation of isoflurane and then killed by cervical dislocation (5, 30) . The uterus was dissected, and whole embryos were exposed. Entire embryonic mouse hearts were then carefully excised from explanted embryos using a dissecting microscope. During the dissection procedure, the embryonic mice were bathed in modified oxygenated Tyrode's solution containing (in mM) 136 NaCl, 5.4 KCl, 0.1 CaCl 2, 0.33 NaH2PO4, 1 MgCl2, 10 HEPES, and 10 glucose (pH 7.3). The same solution with 1.8 mM CaCl 2 was used as the standard bath solution to superfuse embryonic hearts at 37°C in the experimental chamber. To selectively inhibit glycolysis, glucose was replaced with 10 mM pyruvate, and 10 mM 2-deoxyglucose (2DG) or 0.1 mM iodoacetate (IAA) was added (32) . To selectively inhibit oxidative phosphorylation, the protonophore mito-chondrial uncoupler carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP; 500 nM) was added to the standard bath solution (32 Confocal imaging of mitochondrial membrane potential. To monitor the change in mitochondrial membrane potential (⌬⌿ m), the hearts were superfused with Tyrode's solution containing tetramethylrhodamine methyl ester (TMRM; 200 nM). TMRM is a lipophilic, membrane-permeant, monovalent cationic fluorescent dye that distributes itself in the mitochondrial matrix following the Nernst equation (16, 24) . Time series and z stacks of hearts were acquired with a Zeiss LSM 5 Pascal confocal laser scanning microscope (Carl Zeiss, Jena, Germany) equipped with an inverted Axiovert 200 microscope and ϫ10 objective. The combination of a 488-nm argon laser and 505-nm long-pass emission filters was used to visualize TMRM fluorescence. Subsequent image restoration and analysis (such as the intensity measurements) were done with LSM510 VisArt (Carl Zeiss) and Image J (NIH, Bethesda, MD).
Optical mapping. The experimental setup and methods for simultaneous optical imaging of membrane potential and Ca i have been described in detail previously (30) . In brief, for dual voltage and Cai mapping, isolated E10.5 to E11.5 embryonic mouse hearts were incubated with 5 M rhod-2 acetoxymethyl ester (rhod-2 AM) dissolved in dimethyl sulfoxide and Pluronic F-127 (0.1%) for 40 min to image Ca i, followed by a 5-min incubation with 5 M RH-237 to image membrane voltage. Embryonic mouse hearts were then washed in Tyrode's solution before transfer to an experimental chamber (37°C) on a modified inverted microscope. Ca i and voltage signals were simultaneously recorded using two electron-multiplier chargecoupled device (CCD) cameras operating at 200 -500 frames/s (Cascade 128ϩ; Photometrics, Tucson, AZ) with a spatial resolution of 128 ϫ 128 pixels. In control experiments, we documented that with the filter settings used (30), RH-237 and rhod-2 AM fluorescence did not exhibit significant cross talk, confirming previous reports by other investigators using this dye combination (6, 9, 22) . In some experiments Ca i imaging alone was performed, substituting fluo-4 AM for rhod-2 AM using the same dye loading protocol, with a different CCD camera (model LCL 811K; Watec America, Las Vegas, NV) using an ATI video capture card (30 frames/s).
Data were analyzed using custom software, and detailed methods for measuring propagation, Cai transient, and APD are the same as described previously (30) . Cai transient amplitude was measured as the fluorescence intensity difference (⌬F) immediately before systole to the peak during systole, averaged for four to six successive beats. Although activation sequences could be reliably measured from the timing of upstrokes of action potentials or Cai transients from all regions of the hearts, atrial and AV ring voltage recordings typically contained too much motion artifact to measure APD accurately. Therefore, APD at 80% repolarization (APD80) was measured only from ventricular tissue by selecting regions with the least amount of motion. Because the images were not confocal, the fluorescence traces represented an average of cells from both the anterior and posterior regions of the chamber. Care was taken to avoid overlap with the outflow tract, whose activation is delayed relative to the ventricles. AV conduction time was measured as the average time delay between the action potential upstroke (or Cai transient upstroke) from atrial and ventricular recording sites on either side of the AV ring. Student's t-test was used to compare means, with P Ͻ 0.05 considered statistically significant. Figure  1A shows simultaneous dual voltage (V m ) and Ca i fluorescence images of a representative isolated E10.5 embryonic mouse heart during sinus rhythm, indicating the anatomical locations of the atria, AV ring, and ventricles. Figure 1B shows traces of V m and Ca i recorded from representative sites in the atria, AV ring, and ventricles, respectively, during control perfusion with 1.8 mM Ca-Tyrode's solution at 37°C. Figure 1C illustrates the conduction sequence in the form of a space-time plot, in which the y-axis shows the fluorescence intensity along the red line shown in Fig. 1A , plotted as a function of time along the x-axis. The action potential or Ca i transient duration is thus indicated by the thickness of the bright (red-white) region, whereas conduction velocity through the atria, AV ring, and ventricles is proportional to the slope of the left edge of fluorescence trace through that region. The plot demonstrates that the heart beat originated in the atria and propagated slowly through the AV ring (shallow slope) and then rapidly through the ventricles (steep, almost vertical slope). Figure 1D shows pseudocolorized snapshots of Ca i fluorescence at the various times indicated from another E10.5 embryonic mouse heart. Figure 1E shows an isochronal map constructed from the activation times, illustrating rapid conduction through atria, slow conduction through the AV ring (indicated by the bunching together of isochrome lines), and rapid conduction through the ventricles (see also Supplemental Video 1). Supplemental data for this article is available online at the American Journal of Physiology-Heart and Circulatory Physiology website.
RESULTS

Basal conduction properties of mouse embryo hearts.
Effects of selective metabolic inhibition on mitochondrial membrane potential. To image mitochondria, embryonic mouse hearts were superfused at room temperature with control Tyrode's solution containing 200 nM TMRM for 20 min in a chamber positioned on an inverted laser confocal microscope. Figure 2A (see also Supplemental Video 2) illustrates a representative experiment from an E10.5 heart showing the z stack of TMRE fluorescence images. Bright TMRM fluorescence in the atria, AV ring, and ventricle indicates wellpolarized mitochondria in the E10.5 embryonic mouse heart, although individual mitochondria cannot be visualized at this magnification. Similar findings were obtained in 10 additional hearts. Figure 2 , B and C, shows the effects of selective inhibition of glycolysis (0.1 mM IAA and 10 mM pyruvate replacing glucose) versus oxidative phosphorylation (500 nM FCCP with 10 mM glucose present) on TMRM fluorescence. Mean fluorescence intensity was measured from confocal images every 15 s and expressed as the percentage of initial intensity after background subtraction. Neither control superfusion ( Fig. 2A) nor selective glycolytic inhibition with IAA (Fig. 2B) caused any significant decrease in TMRM intensity, documenting that IAA did not cause mitochondrial depolarization. In contrast, selective inhibition of oxidative phosphorylation with the mitochondrial uncoupler FCCP significantly deceased TMRM fluorescence in all regions of the heart within 5 min (Fig. 2C) , consistent with the loss of mitochondrial membrane potential (⌬⌿ m ). The average time course of changes in TMRM fluorescence from five hearts in each group is summarized in Fig.  2D . Similar to IAA, selective inhibition of glycolysis with 10 mM 2DG and 10 mM pyruvate replacing glucose had no significant effect on TMRM fluorescence (data not shown).
Effects of selective metabolic inhibition on electrophysiological function and Ca i . Using dual voltage and Ca i optical mapping, we next characterized the effects of selective inhibition of glycolysis or oxidative phosphorylation on heart rate, conduction time through the AV ring, and ventricular APD 80 . The top panels of Fig. 3 , A-C, illustrate isochronal activation maps during sinus rhythm in three different embryonic mouse hearts under control conditions (A) and after superfusion with 0.1 mM IAA (B) or 500 nM FCCP (C). The middle panels show corresponding V m and Ca i traces (superimposed) from ventricles, and the bottom panels show space-time plots along the lines indicated in the middle panels. Figure 3D summarizes the average changes in heart rate, AV conduction time, and ventricular APD 80 after 2DG, IAA, or FCCP. 2DG, IAA, and FCCP all slowed heart rate to a comparable degree, from 83 Ϯ 2 to 71 Ϯ 3 beats/min (n ϭ 22, P Ͻ 0.05) after 2DG, from 89 Ϯ 2 to 64 Ϯ 2 beats/min (n ϭ 34, P Ͻ 0.001) after IAA, and from 88 Ϯ 3 to 49 Ϯ 3 beats/min (n ϭ 34, P Ͻ 0.001) after FCCP. 2DG had no significant effect on AV conduction time or ventricular APD 80 , whereas both IAA and FCCP significantly prolonged AV conduction time, from 201 Ϯ 15 ms (n ϭ 24) to 243 Ϯ 28 ms with IAA (n ϭ 21, P Ͻ 0.001) and 268 Ϯ 22 ms with FCCP (n ϭ 24, P Ͻ 0.001), and shortened ventricular APD 80 , from 203 Ϯ 14 ms (n ϭ 18) to 135 Ϯ 11 ms with IAA (n ϭ 18, P Ͻ 0.001) and 123 Ϯ 10 ms with FCCP (n ϭ 19, P Ͻ 0.001). The slower heart rate during metabolic inhibition cannot account for the APD shortening, since slowing heart rate typically prolongs APD. Figure 4 , A-C, shows the effects of 2DG, IAA, and FCCP on the ventricular Ca i transient amplitude in three representative embryonic hearts, using each heart as its own control. After 10 min of exposure to selective metabolic inhibition, Ca i transient amplitude declined by 37 Ϯ 7% after 2DG (n ϭ 18, P Ͻ 0.05), Fig. 2 . Effects of selective metabolic inhibition on mitochondrial membrane potential (⌬⌿m). A-C: by using tetramethylrhodamine methyl ester (TMRM) to image ⌬⌿m, confocal images at 1-min intervals reveal that ⌬⌿m remains well-polarized under control conditions (A) and during selective inhibition with glycolysis by iodoacetate (IAA; B) but is rapidly depolarized by the protonophore carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP) during selective inhibition of oxidative phosphorylation (C). D: summary of changes in TMRM fluorescence intensity in 6 control hearts, 5 exposed to IAA and 5 exposed to FCCP. TMRM fluorescence of the whole heart is expressed as a percentage of basal fluorescence vs. time, with images obtained every 15 s. Error bars indicate SD. [See Supplemental Video 2 for laser scanning of stacked (10-m sections) TMRM images in an E10.5 embryonic mouse heart.] 47 Ϯ 6% after IAA (n ϭ 18, P Ͻ 0.05), and 42 Ϯ 5% after FCCP (n ϭ 20, P Ͻ 0.05). Figure 4D summarizes the data from all preparations. In contrast, under control conditions with maintained superfusion with Tyrode's solution, the Ca i transient amplitude decrease due to dye bleaching, and other factors averaged 12 Ϯ 5% over 25-30 min (n ϭ 35), that is, Ͻ5% over the comparable 10-min time course over which the effects of metabolic inhibitors were studied. The modest decrease in heart rate during metabolic inhibition also is unlikely to account for the decrease in Ca i transient amplitude, since under control conditions, increasing heart rate by pacing from 175 to 430 beats/min led to a progressive decrease (averaging 55% in 8 hearts), rather than an increase in Ca i transient amplitude (the typical negative staircase in rodent heart).
Arrhythmias induced by selective metabolic inhibition. In 136 mouse embryo hearts exposed to selective inhibition of glycolysis or oxidative phosphorylation, 77 developed arrhythmias of various types. Arrhythmias occurred with a similar incidence (50 -60%) in both forms of metabolic inhibition (Fig. 5) . The most common types of arrhythmias observed included sinus bradycardia/sinus arrest, AV block, AV ring reentry, and various ventricular arrhythmias, such as premature ventricular contractions, ectopic ventricular rhythms with in- tact ventricular-atrial conduction, and ventricular tachycardia (VT). Ventricular fibrillation (VF) was not observed in any hearts. Figure 6A (see also Supplemental Video 3) shows a typical example of sinus rhythm with 2:1 AV block during exposure to FCCP in an E10.5 heart loaded with fluo-4 AM. In this case, every other atrial Ca i transient failed to propagate through the upper portion of the AV ring area. Figure 6B (see also Supplemental Video 4) shows an example of AV ring reentry in a fluo-4 AM-loaded E10.5 heart exposed to FCCP. Spatially dissociated anterograde and retrograde conduction pathways through the AV ring led to reciprocating tachycardia, analogous to dual AV nodal pathway conduction in adult hearts. Anterograde conduction from the atria proceeded through the AV ring, activated the ventricle, and then immediately turned back through the AV ring to activate the atria retrogradely. The reentrant atrial excitation then failed to propagate through the AVR, terminating reentry. This sequence repeated itself multiple times. In other hearts, reentry was self-sustained for 3-25 min, similar to our group's previous description (30) of AV ring reentry in embryonic mouse hearts induced by combined ␤-adrenergic and muscarinic stimulation. Among the nine hearts exhibiting AV ring reentry, five occurred with FCCP and two with IAA. Figure 6C (see also Supplemental Video 5) shows an example of nonsustained VT in a fluo-4 AM-loaded E10.5 heart during exposure to FCCP. Ca i transient recordings (top) and the corresponding space-time plot (bottom) demonstrate that following each sinus beat, there was a fast salvo of two to five ventricular beats that conducted retrogradely through the AV ring to the atria. To our knowledge, this is the first documentation of rapid VT at such an early embryonic stage. VT was observed in three hearts, two after FCCP and one after IAA.
DISCUSSION
The major finding of this study is that the isolated embryonic mouse heart responds similarly to selective inhibition of either glycolysis or oxidative phosphorylation. Specifically, both forms of metabolic inhibition caused comparable slowing of heart rate, prolongation of AV conduction time, shortening of the ventricular APD, suppression of the ventricular Ca i transient, and a similar incidence and spectrum of arrhythmias. A limitation is that, for technical reasons, we were unable to accurately characterize changes in diastolic Ca i , which may be particularly important for arrhythmogenesis. We also did not pace the heart to exclude the possibility that changes in heart rate contributed to changes in APD or Ca i transient amplitude. However, in the adult rodent heart, APD and Ca i transient amplitude typically increase as heart rate slows (2, 1), opposite to the changes caused by metabolic inhibition. In control experiments, we also directly confirmed that Ca i transient amplitude in embryonic mouse hearts also decreased at faster heart rates.
We documented that ⌬⌿ m remained normal during selective glycolytic inhibition with either 2DG or IAA, suggesting that with pyruvate present, oxidative phosphorylation was unaffected, whereas selective inhibition of oxidative phosphorylation with the protonophore FCCP caused severe mitochondrial depolarization. Although we did not measure cellular highenergy phosphate levels in the present study, Murphy et al. (21) reported a significant decrease in ATP during exposure to the oxidative phosphorylation inhibitor rotenone (0.1 mM), which was accelerated when combined with glycolytic inhibition by IAA (1 mM). These data suggest that both oxidative and glycolytic pathways are important in maintaining ATP in embryonic hearts. On the other hand, glycolytic ATP accounts for only 5% of total ATP generation in adult mammalian heart (29) , and selective inhibition of glycolysis does not acutely depress cellular high-energy phosphate levels as long as a substrate for oxidative phosphorylation such as pyruvate is available (32) . Whether the same is true in embryonic hearts, however, remains to be demonstrated. Since the developing cardiovascular system normally operates in a hypoxic environment, vertebrate embryonic hearts display a relatively low rate of oxidative phosphorylation (17, 26) . Consequently, it is generally believed that embryonic hearts are more heavily Note that the first atrial beat conducts anterogradely through the AVR to the ventricles and then retrogradely back to the atria. The second atrial beat then conducts anterogradely through the AV ring to the ventricles but is unable to conduct retrogradely because of a premature atrial beat, with which it collides in the AVR, terminating reentry. The pattern then repeats (see also Supplemental Video 4). C: nonsustained ventricular tachycardia during selective metabolic inhibition with FCCP. Top, Cai fluorescence traces. Bottom, corresponding space-time plot along a line crossing from the atria through the AVR to the ventricles in an E10.5 embryonic myocyte loaded with fluo-4 AM. Sinus beats are followed by 2-5 beat bursts of VT that conduct retrogradely to the atria (see also Supplemental Video 5). dependent on glycolysis. In the adult heart, selective inhibition of glycolysis has qualitatively different functional consequences than selective inhibition of oxidative phosphorylation (27, 32) . These differences may be related to preferential energy channeling as the heart matures (28, 34) . Specifically, it has been proposed that glycolytically derived ATP may be preferentially available to membrane-bound pumps and ion channels (3, 4, 11, 13, 15, 18, 23, 27, 32, 33) , whereas mitochondrial ATP may be preferentially utilized by the contractile apparatus, with creatine kinase and adenylate kinase acting to facilitate high-energy phosphate delivery to these compartments in the heart. Since our study in intact embryonic heart revealed no obvious differences between selective inhibition of glycolysis and oxidative phosphorylation, this may imply that the development of cardiac energy channeling occurs postnatally, in response to the greater diffusion limitations of high-energy phosphates as the size of cardiac myocytes increases, as well as with the switch of excitation-contraction coupling from primarily transsarcolemmal Ca fluxes to predominantly intracellular Ca cycling as the sarcoplasmic reticulum matures. However, it is also possible that our optical mapping techniques are not sufficiently sensitive to detect subtle differences in metabolic responses. Different functional effects of selective metabolic inhibition have been noted previously in cultured embryonic chick heart cells (8, 10), although cultured cells may rapidly differentiate (6) . Finally, since we studied isolated embryonic hearts, we cannot exclude the possibility that embryonic hearts in vivo behave differently.
The mechanism of arrhythmias during selective metabolic inhibition is unknown. However, the similar incidence and types of arrhythmias observed after selective inhibition of either glycolysis or oxidative phosphorylation suggests that they share a common metabolic etiology. Sinus bradycardia may be related to suppression of the Ca i transient, which has recently been shown to play a key role in pacemaking by sinus node (19) and embryonic heart cells (31). Our findings establish that reentry during metabolic inhibition is possible despite the small size of the embryonic heart at this stage (Ͻ2 mm in diameter), since we observed AV ring reentry (Fig. 6 ) in 9 of 136 hearts. Whether the ventricular arrhythmias were due to automaticity, triggered activity, or reentry, however, remains a matter of speculation. In none of 136 hearts exposed to selective metabolic inhibition was VF detected. The heart may be too small at this stage to support multiple wavelets, since even in adult murine hearts, VF is uncommon and usually nonsustained.
In summary, using optical mapping techniques to record mitochondrial membrane potential, membrane voltage, and Ca i in embryonic mouse hearts, we found that selective inhibition of oxidative phosphorylation or glycolysis has roughly equivalent effects of decreasing heart rate, shortening APD, suppressing the amplitude of the Ca i transients, prolonging AV conduction time, and causing arrhythmias. These findings support the hypothesis that oxidative phosphorylation and glycolysis are both critically important for embryonic cardiac function.
